Please use this identifier to cite or link to this item:
|Title:||Risk stratification for covert invasive cancer among patients referred for colonic endoscopic mucosal resection: A large multicenter cohort.|
|Epworth Authors:||Brown, G. J.|
|Other Authors:||Burgess, N. G.|
Hourigan, L. F.
Zanati, S. A.
Williams, S. J.
Raftopoulos, S. C.
Bourke, M. J.
Colorectal Sessile Polyps
Laterally Spreading Lesions
Submucosal Invasive Cancer
Endoscopic Submucosal Dissection
Endoscopic Mucosal Resection
Kudo Pit Pattern
General Surgery and Gastroenterology Clinical Institute, Epworth HealthCare, Victoria, Australia
Cancer Services Clinical Institute, Epworth HealthCare, Victoria, Australia
|Citation:||Gastroenterology. 2017 Sep;153(3):732-742.e1.|
|Abstract:||BACKGROUND & AIMS: Among patients with large colorectal sessile polyps or laterally spreading lesions, it is important to identify those at risk for submucosal invasive cancer (SMIC). Lesions with overt endoscopic evidence of SMIC are referred for surgery, although those without these features might still contain SMIC that is not visible on endoscopic inspection (covert SMIC). Lesions with a high covert SMIC risk might be better suited for endoscopic submucosal dissection than for endoscopic mucosal resection (EMR). We analyzed a group of patients with large colon lesions to identify factors associated with SMIC, and examined lesions without overt endoscopic high-risk signs to determine factors associated with covert SMIC. METHODS: We performed a prospective cohort study of consecutive patients referred for EMR of large sessile or flat colorectal polyps or laterally spreading lesions (≥20 mm) at academic hospitals in Australia from September 2008 through September 2016. We collected data on patient and lesion characteristics, outcomes of procedures, and histology findings. We excluded serrated lesions from the analysis of covert SMIC due to their distinct phenotype and biologic features. RESULTS: We analyzed 2277 lesions (mean size, 36.9 mm) from 2106 patients (mean age, 67.7 years; 53.2% male). SMIC was evident in 171 lesions (7.6%). Factors associated with SMIC included Kudo pit pattern V, a depressed component (0-IIc), rectosigmoid location, 0-Is or 0-IIa+Is Paris classification, non-granular surface morphology, and increasing size. After exclusion of lesions that were obviously SMIC or serrated, factors associated with covert SMIC were rectosigmoid location (odds ratio, 1.87; P = .01), combined Paris classification, surface morphology (odds ratios, 3.96-22.5), and increasing size (odds ratio, 1.16/10 mm; P = .012). CONCLUSIONS: In a prospective study of 2106 patients who underwent EMR for large sessile or flat colorectal polyps or laterally spreading lesions, we associated rectosigmoid location, combined Paris classification and surface morphology, and increasing size with increased risk for covert malignancy. Rectosigmoid 0-Is and 0-IIa+Is non-granular lesions have a high risk for malignancy, whereas proximally located 0-Is or 0-IIa granular lesions have a low risk. These findings can be used to inform decisions on which patients should undergo endoscopic submucosal dissection, EMR, or surgery.|
|Affiliated Organisations:||Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South Wales, Australia|
Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
Department of Gastroenterology and Hepatology, The Alfred Hospital, Melbourne, Victoria, Australia
Westmead Clinical School, University of Sydney, School of Medicine, Sydney, New South Wales, Australia
Gallipoli Medical Research Institute, School of Medicine, The University of Queensland, Greenslopes Private Hospital, Brisbane, Queensland, Australia
Department of Gastroenterology and Hepatology, Western Hospital, Melbourne, Victoria, Australia
Department of Gastroenterology and Hepatology, Lyell McEwin Hospital, Adelaide, South Australia, Australia
Department of Gastroenterology and Hepatology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
University of Sydney National Health and Medical Research Council Clinical Trials Centre, Sydney, New South Wales, Australia.
Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia.
|Type of Clinical Study or Trial:||Multicentre Studies|
|Appears in Collections:||Cancer Services|
General Surgery and Gastroenterology
Files in This Item:
There are no files associated with this item.
Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.